Table 1.
PHLPP levels in cancer and normal tissue.
Sample Type | PHLPP expression | Detection | Reference |
---|---|---|---|
Human Cancer | |||
Breast | PHLPP1 mRNA is 2.0 fold lower in invasive ductal breast carcinoma | Array | [74] |
Breast | PHLPP1 mRNA is 2.3 fold lower in ductal breast carcinoma | Array | [75] |
CLL | PHLPP1 mRNA is 12.4 fold lower in CLL | Array | [76] |
CLL | PHLPP1 mRNA is 5.5 fold lower in CLL | Array | [77] |
CLL with 13q14 deletion | PHLPP1 mRNA is absent in >50% of cases with 13q14 deletion | qPCR | [78] |
Colon | PHLPP2 mRNA is 5 fold lower in colon cancer | Array | [79] |
Colon | PHLPP2 mRNA is 6.1-fold lower in rectal adenoma | Array | [79] |
Colon | PHLPP2 mRNA is 3.5-3.9 fold lower in several types of colon adenoma | Array | [80] |
Colon | PHLPP2 mRNA is 2 fold lower in colorectal adenoma | Array | [81] |
Colon | PHLPP1 and PHLPP2 protein expressions are lost or reduced in 78 and 86% of tumour tissue samples, respectively | IHC | [22] |
Oesophageal | PHLPP1 mRNA is 5.0 fold lower in oesophageal adenocarcinoma | Array | [82] |
Oesophageal | PHLPP2 mRNA is 3.8 fold lower in oesophageal adenocarcinoma | Array | [82] |
GBM | PHLPP1 mRNA is 2.1 fold lower in GBM | Array | [83] |
Liver, Pancreas, Stomach | PHLPP1 protein expression is significantly decreased in liver, pancreas, and stomach tumour samples | IHC | [32] |
Mantle Cell Lymphoma | PHLPP1 mRNA is 4.3 fold lower in mantle cell lymphoma | Array | [76] |
Melanoma | PHLPP2 mRNA is 2.3 fold lower in benign melanocytic skin novus | Array | [84] |
Pancreatic ductal adenocarcinoma | Low PHLPP1 but not PHLPP2 protein expression is negatively correlated with survival | IHC | [25] |
Prostate | PHLPP1 mRNA is significantly reduced in high Gleason Score tumours | qPCR | [47] |
Prostate | PHLPP1 and PHLPP2 mRNAs are absent in 30% and 50% of prostate tumours, respectively | Array | [26] |
Prostate | PHLPP1 protein expression is 4 fold lower in PTEN-null, AR-null prostate cancer compared to benign lesions | IHC | [60] |
Normal tissue | |||
Various rat tissues | PHLPP1β protein is expressed in testis, hypothalamus, hippocampus, cortex, olfactory bulb, and cerebellum | WB | [1] |
Various human tissues | PHLPP1 mRNA is strongly expressed in brain, heart, skeletal muscle, kidney, liver, small intestine, placenta, lung | Northern blot | [23] |
Mouse T cells | PHLPP1 and 2 mRNAs are increased by 7 and two fold, respectively, in Tregs compared to Tconv | RT-PCR | [35] |
Mouse hippocampus | PHLPP1 and 2 protein levels are 30-50% lower in CA1 compared to CA3 | WB | [12] |
Rat SCN | PHLPP1β mRNA is higher at clock time 0 than clock time 12 | RT-PCR | [1] |
Mouse striatum | PHLPP1 protein levels are ∼50% lower in mouse models of Huntington's disease | WB | [34] |
Human putamen | PHLPP1 protein levels are ∼80% lower in Huntington's patients | WB | [34] |
Rat liver | PHLPP2 mRNA levels are 23.4 fold higher in rats given lanthanum nitrate | Array | [85] |
Human skeletal muscle | PHLPP1 protein is increased ∼two fold in obese versus non-obese subjects | WB | [21] |
Human white adipose tissue | PHLPP1 protein is increased ∼two fold in obese versus non-obese subjects | WB | [21] |